Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.150
+0.070 (6.48%)
At close: Feb 19, 2026, 4:00 PM EST
1.150
0.00 (0.03%)
After-hours: Feb 19, 2026, 5:07 PM EST
Humacyte Market Cap
Humacyte has a market cap or net worth of $221.95 million as of February 19, 2026. Its market cap has decreased by -59.89% in one year.
Market Cap
221.95M
Enterprise Value
253.43M
1-Year Change
-59.89%
Ranking
Category
Stock Price
$1.15
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $221.95M, an increase of 78.55%. That is a compound annual growth rate of 11.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 208.44M | 12.44% |
| Dec 31, 2025 | 185.37M | -71.47% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orchestra BioMed Holdings | 225.86M |
| Achieve Life Sciences | 223.05M |
| Heron Therapeutics | 221.87M |
| MediWound | 219.63M |
| Alector | 216.67M |
| Surrozen | 215.06M |
| Arcturus Therapeutics Holdings | 213.39M |
| Context Therapeutics | 213.16M |